A more recent version of this regulatory record is available. This version is kept only as a historical record. Please see the Record history section for link to the most recent version.

Dioctyltin dilaurate


List details

Basic info

Status Opinion Adopted
Submitter Sweden
Regulatory programme
  • Other substance
Remarks STOT RE target organ: immune system


Proposed harmonised classification by the dossier submitter
  • Repr. 1B, H360D
  • STOT RE 1, H372
Hazard classes open for commenting Reproductive toxicity Specific target organ toxicity — repeated exposure
Proposed specific concentration limits by the dossier submitter SCLs for Repro evaluated and concluded not justified (proposed for source substane, see Internal remarks).

Intention timeline

Date of intention 2015-09-18
Expected date of submission 2017-01-31
Submitted for accordance check 2017-03-10
Final submission date 2017-08-14
Start of consultation 2017-10-17
Deadline for commenting 2017-12-01
Date of opinion 2018-09-14
Legal deadline for opinion adoption 2019-03-14


CLH report
Annexes to the CLH Report
Comments received
Public consultations - received attachments
RAC opinion
Background document external link [echa.europa.eu]

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

April 4, 2019
  • Regulatory programme: Other substanceChemical registered under REACH
This version
Nov. 22, 2018
  • Background document: https://echa.europa.eu/documents/10162/80fa8eef-0abb-5af0-f594-941e2e54bef8
  • Comments received: https://echa.europa.eu/documents/10162/67f6d1b0-f511-72e3-cae6-42e0a9eac58chttps://echa.europa.eu/documents/10162/995e47de-fa60-f098-ff78-150f37b1f2d5
  • RAC opinion: https://echa.europa.eu/documents/10162/2d5e92f9-5e3f-dc37-e926-be5abeffc355
Oct. 16, 2018
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/3e23462a-7ff9-af7a-cd48-e88019867ba5
  • Date of opinion: 2018-09-14
  • Status: Opinion DevelopmentOpinion Adopted
Add the related substance to your watchlist to monitor this regulatory record.